Lung Cancer

Web Exclusives | May 24, 2022
Recent survey results of physicians who treat patients with non–small-cell lung cancer reveal high biomarker testing rates, but treatment decisions frequently depend on test result turnaround time.
Web Exclusives | May 24, 2022
Newly diagnosed patients who adhered to tumor board recommendations for treatment have a longer overall survival time than patients who only partially adhered or did not adhere to recommendations.
Web Exclusives | May 24, 2022
Patients with KRAS G12C non–small-cell lung cancer appear to have improved progression-free survival before immunotherapy than patients with non-KRAS G12C lung cancer, but there was no improvement in overall survival between the 2 groups.
Web Exclusives | May 24, 2022
More severe interstitial lung disease with more severe radiological features was found on second occurrence in patients with lung cancer who were rechallenged with ICI treatment.
Web Exclusives | April 27, 2022
Liquid biopsy improves turnaround time for molecular genotyping, but further improvement in next-generation sequencing is recommended.
Web Exclusives | April 27, 2022
A recent study identified several risk factors associated with the development of nephrotoxicity when using pemetrexed in patients with non–small-cell lung cancer.
Web Exclusives | April 27, 2022
Researchers identified an association between nutritional status, treatment protocols, and survival in patients with advanced non–small-cell lung cancer.
Web Exclusives | April 27, 2022
Recently released study findings on PD-1/PD-L1 immunotherapy in young and elderly patients with metastatic NSCLC found the treatment is safe and effective in both patient cohorts.
Web Exclusives | March 28, 2022
Next-generation sequencing for targetable mutations in lung cancer is as accurate as single-gene testing with minimal increase in testing cost.
Web Exclusives | March 28, 2022
Released study results indicate that an interval of ≤50 days from diagnosis to treatment significantly improves outcomes in patients with early-stage lung cancer.
Page 1 of 19
Results 1 - 10 of 182

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code